GLAXOSMITHKLINE ΜΟΝΟΠΡΟΣΩΠΗ A.E.B.E.

GSK is a global biopharmaceutical company aiming to positively impact the health of 2.5 billion people by the end of 2030, prioritizing vaccine and drug research in 4 key therapeutic areas: infectious diseases, HIV, oncology and immunology, uniting science, technology and talent. 

GSK Greece counts more than 50 years of dynamic presence in the country and has more than 80 innovative formulations for respiratory diseases, HIV, rare diseases and oncology, while maintaining the broadest portfolio of vaccines in the industry, for the prevention of all diseases described in the National Vaccination Program for children, adolescents and adults.